These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 26019279

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Type 1 von Willebrand disease mutation Cys1149Arg causes intracellular retention and degradation of heterodimers: a possible general mechanism for dominant mutations of oligomeric proteins.
    Bodó I, Katsumi A, Tuley EA, Eikenboom JC, Dong Z, Sadler JE.
    Blood; 2001 Nov 15; 98(10):2973-9. PubMed ID: 11698279
    [Abstract] [Full Text] [Related]

  • 24. Advancing multimer analysis of von Willebrand factor by single-molecule AFM imaging.
    Löf A, König G, Schneppenheim S, Schneppenheim R, Benoit M, Budde U, Müller JP, Brehm MA.
    PLoS One; 2019 Nov 15; 14(1):e0210963. PubMed ID: 30645640
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type 1 von Willebrand disease.
    Cumming A, Grundy P, Keeney S, Lester W, Enayat S, Guilliatt A, Bowen D, Pasi J, Keeling D, Hill F, Bolton-Maggs PH, Hay C, Collins P, UK Haemophilia Centre Doctors' Organisation.
    Thromb Haemost; 2006 Nov 15; 96(5):630-41. PubMed ID: 17080221
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Characterization of a novel mutation in the von Willebrand factor propeptide in a distinct subtype of recessive von Willebrand disease.
    Lanke E, Kristoffersson AC, Philips M, Holmberg L, Lethagen S.
    Thromb Haemost; 2008 Aug 15; 100(2):211-6. PubMed ID: 18690339
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Laboratory and molecular characteristics of recessive von Willebrand disease type 2C (2A subtype IIC) of variable severity due to homozygous or double heterozygous mutations in the D1 and D2 domains.
    Michiels JJ, Gadisseur A, van der Planken M, Schroyens W, Berneman Z.
    Acta Haematol; 2009 Aug 15; 121(2-3):111-8. PubMed ID: 19506357
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Reduced von Willebrand factor secretion is associated with loss of Weibel-Palade body formation.
    Castaman G, Giacomelli SH, Jacobi PM, Obser T, Budde U, Rodeghiero F, Schneppenheim R, Haberichter SL.
    J Thromb Haemost; 2012 May 15; 10(5):951-8. PubMed ID: 22429825
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.